{
    "2019-06-06": [
        [
            {
                "time": "",
                "original_text": "股获券商买入评级 智飞生物目标涨幅达68.82%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "券商",
                        "买入评级",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "芯片并购潮起：紫光国微拟180亿并购Linxens 协同效应几何？",
                "features": {
                    "keywords": [
                        "芯片",
                        "并购",
                        "紫光国微",
                        "Linxens",
                        "协同效应"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "半导体",
                        "芯片"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}